Clinical Trial Update: Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Formosa 1-Breath Free (NRICM101) for efficacy and safety in subjects with COVID-19 or influenza-like illness; status is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Viral Infections

Drugs mentioned

• Formosa 1-Breath Free (NRICM101)

Snippet

Sponsor: China Medical University Hospital | Conditions: Influenza Viral Infections, COVID-19 | Phase 3 | Status: UNKNOWN